Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma

Diseases of the Esophagus

Volumn 27, Issue 2, 2014, Pages 168-175

  Wang, J ^a   Myles, B ^a   Wei, C ^a   Chang, J Y ^a   Hofstetter, W L ^a   Ajani, J A ^a   Swisher, S G ^a   Cox, J D ^a   Komaki, R ^a   Liao, Z ^a   Lin, S H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Esophageal cancer; Obesity; Outcome

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADULT; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; FEMALE; FISTULA; GASTROINTESTINAL DISEASE; HOSPITAL READMISSION; HUMAN; ILEUS; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LENGTH OF STAY; LEUKOPENIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NAUSEA; NEUTROPENIA; OBESITY; OVERALL SURVIVAL; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RACE; RADIATION DOSE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; THORACOTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ESOPHAGEAL CANCER; OBESITY; OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893017192     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12074     Document Type: Article

References (21)

1. Blanck H M, Dietz W H, Galuska D A etal. State-specific prevalence of obesity among adults-United States, 2005. Centers for Diseases Control and Prevention. MMWR Morb Mortal Wkly Rep 2006; 55: 985-988.
2. Hedley A A, Ogden C L, Johnson C L, Carroll M D, Curtin L R, Flegal K M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-2850.
3. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411 (6835): 390-395.
4. Lew E A, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis 1979; 32: 563-576.
5. Bastarrachea J, Hortobagyi G N, Smith T L, Kau S W, Buzdar A U. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994; 120: 18-25.
6. Litton J K, Gonzalez-Angulo A M, Warneke C L etal. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 2008; 26: 4072-4077.
7. Fujitani K, Ajani J A, Crane C H etal. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 2007; 14: 2010-2017.
8. Healy L A, Ryan A M, Gopinath B, Rowley S, Byrne P J, Reynolds J V. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg 2007; 134: 1284-1291.
9. Kilic A, Schuchert M J, Pennathur A etal. Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg 2009; 87: 412-415.
10. Morgan M A, Lewis W G, Hopper A N etal. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus 2007; 20: 29-35.
11. Hayashi Y, Correa A M, Hofstetter W L etal. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 2010; 116: 5619-5627.
12. Melis M, Weber J M, McLoughlin J M etal. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol 2011; 18: 824-831.
13. van Hagen P, Hulshof M C, van Lanschot J J etal. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
14. Blom R L, Lagarde S M, Klinkenbijl J H, Busch O R, van Berge Henegouwen M I. A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival. Ann Surg Oncol 2012; 19: 766-771.
15. Hayashi Y, Correa A M, Hofstetter W L etal. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 2012; 25: 614-622.
16. Greene F L, Page D L, FLeming I D etal. AJCC Cancer Staging Handbook, 6th edn. New York: Springer-Verlag, 2002.
17. Meyerhardt J A, Catalano P J, Haller D G etal. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98: 484-495.
18. Griggs J J, Sorbero M E, Lyman G H. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 2005; 165: 1267-1273.
19. Heath E I, Burtness B A, Heitmiller R F etal. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000; 18: 868-876.
20. Grotenhuis B A, Wijnhoven B P, Hotte G J, van der Stok E P, Tilanus H W, van Lanschot J J. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg 2010; 34: 2621-2627.
21. Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.